James B. Renacci bought Teva Pharma Industries Ltd ADR (NYSE: TEVA)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 8 trades in Teva Pharma Industries Ltd ADR (TEVA) since 2014, 4 purchases and 4 sales, worth an estimated $113K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $1,000 - $15,000 of Teva Pharma Industries Ltd ADR (NYSE: TEVA) on July 17, 2014. Since that trade, TEVA is down -27.35% against the S&P 500 up +362.31%, an outperformance of -389.65%.
Across these filings, James B. Renacci has been a balanced trader of TEVA (a buy-to-sell ratio of 1.00). The most recent disclosed TEVA transaction shown was dated December 20, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's TEVA trades vs the price
TEVA is down -27.35% since James B. Renacci bought on July 17, 2014, versus +362.31% for the S&P 500.
Performance since this trade
All James B. Renacci TEVA trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & TEVA trading FAQ
Is it legal for James B. Renacci to trade Teva Pharma Industries Ltd ADR (TEVA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Teva Pharma Industries Ltd ADR (TEVA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy TEVA?
James B. Renacci disclosed a purchase of $1,000 - $15,000 of Teva Pharma Industries Ltd ADR (TEVA) on July 17, 2014, according to public STOCK Act filings.
How has TEVA performed since James B. Renacci's trade?
Since James B. Renacci bought TEVA on July 17, 2014, the stock is down -27.35%, versus +362.31% for the S&P 500 over the same period, an outperformance of -389.65%.
How many times has James B. Renacci traded TEVA?
James B. Renacci has disclosed 8 TEVA trades since 2014 (4 purchases and 4 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional TEVA trades?
Quantellect tracks every disclosed congressional trade in Teva Pharma Industries Ltd ADR (TEVA) on the Teva Pharma Industries Ltd ADR congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's TEVA tradesAll congressional filings for Teva Pharma Industries Ltd ADRJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.